$2.17B
$10.5 Million
0.0% of portfolio
146,410
Q3 2024
Reduced 19.11%
$0
$1.53 Million
0.0% of portfolio
14,156
Q4 2022
Reduced 10.6%
$400M
$514,000
0.0% of portfolio
6,424
Q3 2024
Reduced 26.35%
$423M
$612,000
0.0% of portfolio
100,687
Q3 2024
Added 1.5%
$9.74B
$7.56 Million
0.0% of portfolio
27,439
Q3 2024
Added 13.3%
$2.04B
$1.43 Million
0.0% of portfolio
27,520
Q3 2024
Added 51.33%
$658M
$873,000
0.0% of portfolio
38,915
Q3 2024
Added 5.7%
$3.66B
$4.88 Million
0.0% of portfolio
53,870
Q3 2024
Added 0.77%
$372M
$202,000
0.0% of portfolio
55,108
Q2 2024
Added 40.22%
$1.04B
$2.59 Million
0.0% of portfolio
59,958
Q3 2024
Added 358.25%
$14.1B
$5.22 Million
0.0% of portfolio
470,294
Q3 2024
Reduced 3.17%
$11B
$18.5 Million
0.0% of portfolio
165,102
Q3 2024
Added 1.64%
$3.74B
$2.77 Million
0.0% of portfolio
15,194
Q3 2024
Added 8.34%
Syros Pharmaceuticals Inc
-
$49,000
0.0% of portfolio
-
Q1 2023
Added 85.6%
$0
$271,000
0.0% of portfolio
9,594
Q3 2024
Added 3.91%
$731M
$971,000
0.0% of portfolio
46,386
Q3 2024
Added 9.06%
$1.47B
$1.25 Million
0.0% of portfolio
20,130
Q3 2024
Added 5.62%
$512M
$1.63 Million
0.0% of portfolio
164,657
Q3 2024
Added 24.38%
$3.47B
$27.3 Million
0.0% of portfolio
322,699
Q3 2024
Reduced 8.52%
$69.4M
$171,000
0.0% of portfolio
37,404
Q3 2024
Added 8.9%
$83.8M
$262,000
0.0% of portfolio
59,290
Q2 2024
Reduced 50.32%
$497M
$670,000
0.0% of portfolio
122,484
Q3 2024
Added 0.45%
Inovio Pharmaceuticals Inc
-
$120,000
0.0% of portfolio
-
Q2 2024
Added 65.23%
$0
$439,000
0.0% of portfolio
4,504
Q3 2024
Added 30.74%
$919M
$521,000
0.0% of portfolio
6,867
Q3 2024
Added 0.85%
$3.35B
$1.66 Million
0.0% of portfolio
71,717
Q3 2024
Added 4.87%
$3.83B
$13.8 Million
0.0% of portfolio
63,538
Q3 2024
Added 330.27%
$349M
$264,000
0.0% of portfolio
18,002
Q3 2024
Added 0.94%
$2.14B
$1.46 Million
0.0% of portfolio
56,623
Q3 2024
Added 1.13%
$3.1B
$2.67 Million
0.0% of portfolio
119,109
Q3 2024
Added 1.69%
$416M
$257,000
0.0% of portfolio
19,944
Q3 2024
Added 1.4%
$799M
$255,000
0.0% of portfolio
8,374
Q3 2024
New
$241M
$121,000
0.0% of portfolio
45,700
Q3 2024
Added 36.42%
$91.7M
$98,000
0.0% of portfolio
108,204
Q3 2024
Reduced 34.58%
$566M
$863,000
0.0% of portfolio
19,679
Q3 2024
Reduced 7.86%
$2.47B
$890,000
0.0% of portfolio
18,952
Q3 2024
Added 67.76%
$1.86B
$562,000
0.0% of portfolio
15,235
Q3 2024
Added 3.3%
$1.86B
$36.6 Million
0.0% of portfolio
555,364
Q3 2024
Added 8.6%
$6.53B
$37 Million
0.0% of portfolio
883,469
Q3 2024
Added 40.06%
$3.91B
$2.35 Million
0.0% of portfolio
26,974
Q3 2024
Added 5.57%
$0
$456,000
0.0% of portfolio
800
Q3 2024
Reduced 81.17%
$2.06B
$910,000
0.0% of portfolio
21,933
Q3 2024
Added 5.23%
$8.76B
$4.78 Million
0.0% of portfolio
42,727
Q3 2024
Added 3.71%
$1.66B
$1.35 Million
0.0% of portfolio
59,851
Q3 2024
Added 0.66%
$3.14B
$2.44 Million
0.0% of portfolio
31,490
Q3 2024
Reduced 49.43%
$1.31B
$321,000
0.0% of portfolio
43,748
Q3 2024
Reduced 4.29%
$133M
$109,000
0.0% of portfolio
26,473
Q3 2024
Added 8.36%
$2.55B
$1.57 Million
0.0% of portfolio
11,347
Q3 2024
Added 1.62%
$8.64B
$5.13 Million
0.0% of portfolio
94,971
Q3 2024
Added 6.59%
$900M
$567,000
0.0% of portfolio
23,380
Q3 2024
Added 2.37%